Rutgers Cancer Institute of New Jersey has named Todd Demmy, MD, FACS, FCCP, as its new Chief of Thoracic Oncology and Associate Chief of the Division of Surgical Oncology. Dr. Demmy, who is leading Rutgers Cancer Institute’s Thoracic Oncology Program, is an international leader in minimally invasive thoracic surgery and one of the pioneers of video-assisted thoracoscopic surgery (VATS). Dr. Demmy was most recently at Roswell Park Cancer Institute, where he served as Clinical Chair of Thoracic Surgery and Professor of Oncology.
Dr. Demmy has been recognized internationally for advanced VATS operations, including chest wall resections, the first United States VATS extrapleural pneumonectomy, and the world’s largest series of thoracoscopic pneumonectomies.
While lung disease has been a major component of his scholarly work, Dr. Demmy also maintained a busy clinical practice in foregut surgery by founding the first minimally invasive esophagectomy program in Buffalo, New York, more than 10 years ago. Dr. Demmy, who also was appointed Professor in the Department of Surgery and Chief, Section of Thoracic Surgery, within the Division of Cardiothoracic Surgery at Rutgers Robert Wood Johnson Medical School, performs many laparoscopic and thoracoscopic operations for benign esophageal diseases like repair of large hiatal hernias.
Dr. Demmy received his medical degree from Jefferson Medical College. He completed a general surgery internship at Baylor College of Medicine, followed by a residency and research fellowship in cardiothoracic and cardiovascular surgery at Allegheny General Hospital-West Campus, Medical College of Pennsylvania.
Prior to his extensive work at Roswell Park Cancer Institute, Dr. Demmy served as Chief of Thoracic Oncology, Codirector of Cardiac Transplantation, and Associate Professor of Surgery at University of Missouri Hospital and Clinics and Ellis Fischel Cancer Center. ■
